We find that both BRD2 and BRD4 but not BRD3 are required for liver cancer cell growth, and even transient BET suppression using pan-BETis (JQ-1 and ABBV075) is sufficient to impede cell proliferation and xenograft tumor growth. Here, BRD3 is linked to neoplasm.